Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-κB and AP-1

Carcinogenesis

Volumn 29, Issue 1, 2008, Pages 147-156

  Weng, Chia Jui ^a   Chau, Chi Fai ^a   Hsieh, Yih Shou ^b   Yang, Shun Fa ^b   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTINEOPLASTIC AGENT; GANODERMA LUCIDUM EXTRACT; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIDENIC ACID B; MITOGEN ACTIVATED PROTEIN KINASE 1; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; NF-KAPPA B; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRITERPENES;

EID: 38849178686     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm261     Document Type: Article

References (45)

1. Monvoism,A. et al. (1999) Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J. Hapatol., 30 511-518.
2. Ray,J. M. et al. (1994) The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J., 7, 2062-2072.
3. Kleiner,D.E. et al. (1999) Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol., 43, S41-S51.
4. Rao,J.S. (2003) Molecular mechanisms of glioma invasiveness: The role of proteases. Nat. Rev. Cancer, 3, 489-501.
5. Sato,H. et al. (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8, 395-405.
6. Takada,Y. et al. (2004) Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappa B-mediated gene expression and up-regulation of apoptosis. J. Biol. Chem., 279, 15096-15104.
7. Akool,el-S. et al. (2003) Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA stabilizing factor HuR. Mol. Cell Biol., 23, 4901-4916.
8. Aguirre,G.J.A. et al. (1999) Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J. Biochem., 263, 295-304.
9. Westermarck,J. et al. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J., 13 781-792.
10. Sugita,K. (1999) Recent advances in inhibitors of metalloproteinases for cancer therapy. IDrugs, 2, 327-339.
11. Wojtowicz-Praga,S. (1999) Clinical potential of matrix metalloproteinase inhibitors. Drugs R D., 1, 117-129.
12. Kohn,E.C. et al. (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res., 55, 1856-1862.
13. Basset,P., et al. (1997) Matrix metalloproteinases as strarnal effectors of human carcinoma progression: Therapeutic implications. Matrix Biol., 15, 535-541.
14. Chung,T.W. et al. (2002) Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Arch Biochem. Biophys., 408, 147-154.
15. Itoh,Y. et al. (2002) Matrix metalloproteinases in cancer. Essays Biochem., 38, 21-36.
16. Takahra,T. et al. (2004) Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: Regulation by NF-kappaB, AP-1 and Sp1. Int. J. Biochem Cell Biol., 36, 353-363.
17. Gum,R. et al. (1997) Regulation of 92-kDa type IV collagenase expression by the jun aminoterminal. Idnase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oneogene, 14, 1481-1493.
18. Newton,A.C. (1997) Regulation of protein kinase C. Curr. Opin. Cell Biol., 9, 161-167.
19. Zeigler,M.E. et al. (1999) Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J. Cell. Physiol., 180, 271-284.
20. Hozumi,A. et al. (2001) Induction of MMP-9 in normal human bronchial epithelial cells by TNF-α via NF-kB-mediated pathway. Am J. Physiol. Lung. Cell. Mol. Physiol., 281, L1444-L1452.
21. Liu,P. et al. (2002) Activation of NF-kB, AP-1, and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas. J. Hepatol., 37, 63-71.
22. Zhang,M. et al. (2004) RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene, 23, 3080-3088.
23. Teow,S.S. (1997) The effective application of Ganoderma nutriceuticals. In Kim,B.K.,Moon,C.K. and Kim,T.S. (eds.) Recent Progress in Ganoderma lucidum Research. The Pharmaceutical Society of Korea, Seoul, pp. 21-39.
24. Hsieh,C. et al. (2004) Reusing soy residue for the solid-state fermentation of Ganoderma lucidum. Bioresour. Technol., 91, 105-109.
25. Song,Y.S. et al. (2004) Antiangrogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J. Ethnophamacol., 90, 17-20.
26. Wang,A.C. et al. (2002) Ganoderma (in Chinese). Beijing Science and Technology Press, Beijing, China.
27. Wang,Y.Y. et al. (2002) Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides: Functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorg. Med. Chem., 10, 1057-1062.
28. Yang,H.L. et al. (2002) The relationship between molecular structure and activity of Ganoderma acids (in Chinese with an English abstract). J. Wuxi. Univ. Light Ind., 21, 249-253.
29. Weng,C.J. et al. (2007) The anti-invasive effects of lucidenic acids isolated from a new Ganoderma lucidum strain, Mol. Nutr. Food Res., 51, 1472-1477.
30. Repesh,L.A. (1989) A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis., 9, 192-208.
31. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye Binding. Anal. Biochem., 72, 248-254.
32. Liu,F. et al. (2001) Regulation of differentiation- and proliferation-inducers on Lewis antigens, α-fucosyltransferase, and metastatic potential in hepatocarcinoma cells. Br. J. Cancer, 84, 1556-1563,
33. Masure,S. et al. (1990) Human hepatoma cells produce an 85-kDa gelatinase regulated by phorbol-12-myristate-43-acetate. Biochim Biophys. Acta., 1054, 317-325.
34. Hah,N. et al. (2003) An absolute role of the PKC-dependent NF-kB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem Biophys. Res. Commun., 305, 428-433.
35. Chung,T.W. et al. (2004) Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J, 18, 1670-1681.
36. Simon,C. et al. (1998) Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res., 58 1135-1139.
37. Genersch,E. et al. (2000) Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci. 113, 4319-4330.
38. Shin,M. et al. (2002) An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding, and PNM-inducible 92-kDa type IV collagenase expression. Biochim. Biophys. Acta., 1589, 311-316.
39. Walker,V.G. et al. (2007) PI-3-Kinase activation is required for PMA directed activation of cSrc by AFAP- 110. Am. J. Physiol. Cell Physiol., 293, 119-132.
40. Schmoll,D. et al. (2001) Phorbol ester-induced activation of mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase and extracellular-signal-regulated protein kinase decreases glucose-6-phosphatase gene expression. Biochem. J., 357, 867-873.
41. Chen,F. et al. (2001) New insights into the role of nuclear factor-kappaB in cell growth regulation. Am. J. Pathol., 159 387-397.
42. Bahassi el,M. et al. (2004) Critical regulation of genes for tumor cell migration by AP-1. Clin. Exp. Metastasis., 21, 293-304.
43. Cheng,J.C. et al. (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene, 25, 7009-7018.
44. Huang,S.C. et al. (2005) Carnosol inhibits the invasion of b 16/ F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappaB and c-Jun. Biochem. Pharmacol. 69, 221-232.
45. Futakuchi,M. et al. (2004) Suppression of metastasis by nuclear factor kB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma. Cancer Sci., 95 18-24.